[HTML][HTML] Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
A Bhamani, J Pepke-Zaba, K Sheares - F1000Research, 2019 - ncbi.nlm.nih.gov
Acute pulmonary embolism (PE) is a disease frequently encountered in clinical practice.
While the management of haemodynamically stable, low risk patients with acute PE is well …
While the management of haemodynamically stable, low risk patients with acute PE is well …
[PDF][PDF] Low-dose systemic thrombolysis in patient with recent major abdominal surgery and high-risk pulmonary embolism: Case report and narrative review
MD Spampinato, F Frezza, SG Nigra - researchgate.net
Introduction: Systemic thrombolysis is the treatment of choice for hemodynamically unstable
patients with acute pulmonary embolism (PE) while for the intermediate-high risk ones the …
patients with acute pulmonary embolism (PE) while for the intermediate-high risk ones the …
[PDF][PDF] THE EFFECTS OF THROMBOLYTIC THERAPY ON PROGNOSTIC CLINICAL MARKERS IN PATIENTS WITH INTERMEDIATE-HIGH RISK PULMONARY …
The objective of the study is to assess the efect of thrombolitic therapy on clinical prognostic
markers in patients with intermediate-high risk pulmonary embolism compared to clasic …
markers in patients with intermediate-high risk pulmonary embolism compared to clasic …
Seguridad y Efectividad de Media Dosis de Alteplasa en Tromboembolia Pulmonar Masiva y Submasiva: Revisión sistematizada y Metaanálisis
JG Paredes-Vázquez, C Jerjes-Sánchez… - repositorio.tec.mx
Introducción La trombólisis con alteplasa en pacientes con tromboembolia pulmonar masiva
y submasiva ha demostrado disminuir mortalidad y revertir la disfunción del ventrículo …
y submasiva ha demostrado disminuir mortalidad y revertir la disfunción del ventrículo …